The AMD risk-conferring variant rs181705462 at the C2/CFB/SKIV2L locus showed suggestive associations with increased FI, C9, C3 and FH peptide levels, in addition to increased C4 levels. This evidence concerns the gene C9 and age-related macular degeneration.